SEGMENT INFORMATION

9 Months Ended

Sep. 30, 2015

SEGMENT INFORMATION [Abstract]

SEGMENT INFORMATION

6.SEGMENT INFORMATION

The Company operates in a single operating segment by selling products through a global network of independent distributors that operates in a seamless manner from market to market, except for its operations in Mainland China.  In Mainland China, the Company utilizes sales employees, independent direct sellers and independent marketers to distribute its products.  Independent direct sellers can sell away from the Company's stores where the Company has obtained a direct selling license to do so.  Independent marketers are licensed business owners who are authorized to sell the Company's products either at their own approved premises or through the Company's stores.  Selling expenses are the Company's largest expense, comprised of sales compensation and incentives paid to its sales force.  The Company manages its business primarily by managing its sales force.  The Company does not use profitability reports on a regional or divisional basis for making business decisions.  However, the Company does report revenue in five geographic regions: Greater China, North Asia, South Asia/Pacific, Americas and EMEA.

NU SKIN ENTERPRISES, INC.

Notes to Consolidated Financial Statements

Revenue generated in each of these regions is set forth below (U.S. dollars in thousands):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
Revenue:	2015		2014		2015		2014
Greater China	$	188,669	$	226,744	$	576,172	$	735,542
North Asia		167,748		205,488		512,757		596,944
South Asia/Pacific		108,857		88,915		247,697		241,762
Americas		70,775		76,737		234,115		246,557
EMEA		35,259		40,916		104,108		139,083
Totals	$	571,308	$	638,800	$	1,674,849	$	1,959,888

Revenue generated by each of the Company's product lines is set forth below (U.S. dollars in thousands):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
Revenue:	2015		2014		2015		2014
Nu Skin	$	324,115	$	392,513	$	1,018,317	$	1,186,592
Pharmanex		245,569		244,690		652,345		768,178
Other		1,624		1,597		4,187		5,118
Totals	$	571,308	$	638,800	$	1,674,849	$	1,959,888

Additional information as to the Company's operations in its most significant geographic areas is set forth below (U.S. dollars in thousands):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
Revenue:	2015		2014		2015		2014
Mainland China	$	138,050	$	152,983	$	421,498	$	518,995
South Korea		104,012		127,094		321,812		359,891
Japan		63,736		78,394		190,945		237,053
United States		52,720		54,241		170,288		170,119

Long-lived assets:	September 30, 2015		December 31, 2014
Mainland China	$	112,915	$	103,445
South Korea		48,977		46,626
Japan		14,404		13,768
United States		272,034		287,103